{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:14:53Z","timestamp":1778055293411,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019820","name":"Promega","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006801","name":"University of Michigan Rackham Graduate School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.slasd.2025.100227","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T21:39:46Z","timestamp":1742593186000},"page":"100227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase"],"prefix":"10.1016","volume":"32","author":[{"given":"Mya D.","family":"Gough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Robers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesear R.","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-6962","authenticated-orcid":false,"given":"Mukesh K.","family":"Nyati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-6960","authenticated-orcid":false,"given":"Peter L.","family":"Toogood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2025.100227_bib0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2571(01)00061-9","article-title":"Regulation of the activity of the pyruvate dehydrogenase complex","volume":"42","author":"Harris","year":"2002","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.slasd.2025.100227_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BFb0031008","article-title":"The mammalian pyruvate dehydrogenase complex: structure and regulation","volume":"96","author":"Wieland","year":"1983","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.slasd.2025.100227_bib0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0079-6603(01)70013-X","article-title":"Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms","volume":"70","author":"Roche","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.slasd.2025.100227_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188568","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev Cancer"},{"key":"10.1016\/j.slasd.2025.100227_bib0005","article-title":"Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.slasd.2025.100227_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fonc.2013.00038","article-title":"Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology","volume":"3","author":"Sutendra","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.slasd.2025.100227_bib0007","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cmdc.201200176","article-title":"Anticancer agents that counteract tumor glycolysis","volume":"7","author":"Granchi","year":"2012","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.slasd.2025.100227_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis in cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J Nat Cancer Instit"},{"key":"10.1016\/j.slasd.2025.100227_bib0009","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/1535-7163.MCT-19-0079","article-title":"Metabolic flexibility in cancer: targeting the pyruvate dehydrogenase kinase: pyruvate dehydrogenase axis","volume":"18","author":"Woolbright","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2025.100227_bib0010","doi-asserted-by":"crossref","first-page":"22700","DOI":"10.1074\/jbc.M801765200","article-title":"Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells","volume":"283","author":"McFate","year":"2008","journal-title":"J Biologic Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0011","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg Effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.slasd.2025.100227_bib0012","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature12154","article-title":"A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence","volume":"498","author":"Kaplon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2025.100227_bib0013","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-Dependent metabolic reprogramming dictates metastatic potential in breast cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.slasd.2025.100227_bib0014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/cells10020325","article-title":"Genetic perturbation of pyruvate dehydrogenase kinase 1 modulates growth, angiogenesis and metabolic pathways in ovarian cancer xenografts","volume":"10","author":"Venturoli","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.slasd.2025.100227_bib0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-022-28737-3","article-title":"The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100227_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jdi.13345","article-title":"Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: therapeutic targets in metabolic diseases","volume":"12","author":"Jeon","year":"2021","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.slasd.2025.100227_bib0017","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2015.39.3.188","article-title":"Pyruvate dehydrogenase kinases: therapeutic targets for diabetes and cancers","volume":"39","author":"Jeoung","year":"2015","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.slasd.2025.100227_bib0018","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2017.11.054","article-title":"Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis","volume":"495","author":"Zhang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.slasd.2025.100227_bib0019","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2337\/db16-0223","article-title":"Inhibition of pyruvate dehydrogenase kinase 2 protects against hepatic steatosis through modulation of tricarboxylic acid cycle anaplerosis and ketogenesis","volume":"65","author":"Go","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.slasd.2025.100227_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/cells13010087","article-title":"A potent PDK4 inhibitor for treatment of heart failure with reduced ejection fraction","volume":"13","author":"Aizawa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.slasd.2025.100227_bib0021","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1038\/s41598-024-62262-1","article-title":"Upregulation of the AMPK-FOXO1-PDK4 pathway is a primary mechanism of pyruvate dehydrogenase activity reduction in tafazzin-deficient cells","volume":"14","author":"Liang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2025.100227_bib0022","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.str.2007.07.001","article-title":"Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol","volume":"15","author":"Kato","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.slasd.2025.100227_bib0023","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.drudis.2015.03.012","article-title":"Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents","volume":"20","author":"Zhang","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.slasd.2025.100227_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107160","article-title":"Recent advances in pyruvate dehydrogenase kinase inhibitors: structures, inhibitory mechanisms and biological activities","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg Chem"},{"issue":"24","key":"10.1016\/j.slasd.2025.100227_bib0025","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.18632\/oncotarget.2656","article-title":"VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells","volume":"5","author":"Moore","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.slasd.2025.100227_bib0026","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/acs.jmedchem.9b00565","article-title":"Identification of novel resorcinol amide derivatives as potent and specific pyruvate dehydrogenase kinase (PDHK) inhibitors","volume":"62","author":"Cho","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chembiol.2016.03.008","article-title":"Small-molecule target engagement in cells","volume":"23","author":"Sch\u00fcrmann","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.slasd.2025.100227_bib0028","doi-asserted-by":"crossref","first-page":"10091","DOI":"10.1038\/ncomms10091","article-title":"Target engagement and drug residence time can be observed in living cells with BRET","volume":"6","author":"Robers","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100227_bib0029","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acs.jmedchem.6b01540","article-title":"Development of dihydroxyphenyl sulfonylisoindoline derivatives as liver-targeting pyruvate dehydrogenase kinase inhibitors","volume":"60","author":"Tso","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0030","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1074\/jbc.M113.533885","article-title":"Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket","volume":"289","author":"Tso","year":"2014","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0031","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.slasd.2025.100227_bib0032","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1042\/bst0311168","article-title":"AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2","volume":"31","author":"Morrell","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.slasd.2025.100227_bib0033","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2021.11.102","article-title":"A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells","volume":"587","author":"Kawano","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.slasd.2025.100227_bib0034","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/0008-5472.CAN-15-1023","article-title":"JX06 Selectively inhibits pyruvate dehydrogenase kinase PDK1 by a covalent cysteine modification","volume":"75","author":"Sun","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.slasd.2025.100227_bib0035","article-title":"Targeting cancer metabolism plasticity with JX06 nanoparticles via inhibiting PDK1 combined with metformin for endometrial cancer patients with diabetes","volume":"9","author":"Yang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.slasd.2025.100227_bib0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-8891-4_3","article-title":"Quantitative, real-time measurements of intracellular target engagement using energy transfer","volume":"1888","author":"Robers","year":"2019","journal-title":"Methods Mole Biol"},{"key":"10.1016\/j.slasd.2025.100227_bib0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2017.10.010","article-title":"Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement","volume":"25","author":"Vasta","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.slasd.2025.100227_bib0038","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1021\/acs.jmedchem.6b01478","article-title":"Application of off-rate screening in the identification of novel pan-isoform inhibitors of pyruvate dehydrogenase kinase","volume":"60","author":"Brough","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0039","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.slasd.2025.100227_bib0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/jm990358+","article-title":"Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase","volume":"43","author":"Aicher","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0041","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/jm9902584","article-title":"(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase","volume":"42","author":"Aicher","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0042","doi-asserted-by":"crossref","first-page":"25305","DOI":"10.1074\/jbc.M802249200","article-title":"Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity","volume":"283","author":"Wynn","year":"2008","journal-title":"J Biologic Chem"},{"key":"10.1016\/j.slasd.2025.100227_bib0043","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj3290191","article-title":"Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex","volume":"329","author":"Bowker-Kinley","year":"1998","journal-title":"Biochemic J"},{"key":"10.1016\/j.slasd.2025.100227_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8201079","article-title":"Dichloroacetate (DCA) and cancer: an overview towards clinical applications","volume":"2019","author":"Tataranni","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.slasd.2025.100227_bib0045","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/biom13121723","article-title":"BODIPY-based molecules for biomedical applications","volume":"13","author":"Das","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.slasd.2025.100227_bib0046","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/cb3005879","article-title":"Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP","volume":"8","author":"Becher","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.slasd.2025.100227_bib0047","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ab.2011.05.039","article-title":"Selective permeabilization for the high-throughput measurement of compartmented enzyme activities in mammalian cells","volume":"416","author":"Niklas","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1016\/j.slasd.2025.100227_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129839","article-title":"Design and synthesis of novel fluorene derivatives as inhibitors of pyruvate dehydrogenase kinase","volume":"109","author":"Inoue","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.slasd.2025.100227_bib0049","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/bi051402s","article-title":"Regulatory roles of the N-terminal domain based on crystal structures of Human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands","volume":"45","author":"Knoechel","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.slasd.2025.100227_bib0050","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/bi7014772","article-title":"Specific ion influences on self-association of pyruvate dehydrogenase kinase Isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the Lipoyl group-binding site inhibitor, Nov3r","volume":"47","author":"Hiromasa","year":"2008","journal-title":"Biochemistry"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:33:00Z","timestamp":1778052780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555225000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":50,"alternative-id":["S2472555225000206"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100227","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100227"}}